| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3B | $3.2B | $0.7B | $3.0B | $2.3B | $0.4B | $0.3B | $0.3B |
| Cost of Revenue | — | — | — | $0.3B | $0.2B | $0.1B | $0.1B | $0.1B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.4B | $0.1B | $-0.2B | $0.3B | $0.4B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $10.84 | $0.71 | $-0.65 | $2.00 | $3.36 | $0.07 | $0.31 | $0.11 |
| EPS (Diluted) | $10.84 | $0.71 | $-0.65 | $2.00 | $3.36 | $0.07 | $0.31 | $0.11 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.5B | $16.5B | $16.9B | $17.1B | $13.5B | $11.2B | $7.8B | $6.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.6B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B |
| Total Liabilities | $5.2B | $9.1B | $9.5B | $9.0B | $6.5B | $5.3B | $3.8B | $3.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $7.0B | $7.1B | $7.1B | $7.8B | $6.6B | $5.5B | $3.8B | $3.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.9B | $0.8B | $0.7B | $0.8B | $0.5B | $0.5B | $0.4B |
| Investing Cash Flow | $4.9B | $-0.3B | $-0.9B | $-3.1B | $-2.3B | $-2.5B | $-1.0B | $-0.7B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-5.2B | $-0.6B | $0.1B | $2.3B | $1.6B | $2.0B | $0.5B | $0.4B |